THE WIRE · № 59230
SciBase announces outcome of rights issue of shares
01 THE MACHINE READ
WHY IT MATTERS.
A small Swedish medtech completes a SEK 57.5m rights issue, diluting holders but shoring up its balance sheet; no listed slug exposure.
Micro-cap capital raise, immaterial to listed markets
Completion and use of proceeds disclosure
Further dilution if cash burn persists
FULL DISPATCH
STOCKHOLM, Oct. 1, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today, on 1 October 2026, announces the outcome of the rights issue of shares of approximately SEK 57.5 million resolved by the Board of Directors on 3 September 2026 pursuant to the...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
Watch Some Oura IPO Investors Were Said to Push Back Citing Valuation2026-09-30 18:12 UTC
Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables2026-10-01 08:00 UTC
Underfunded, under-researched, underserved: revenge year for women’s health M&A2026-10-01 00:45 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.